Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons
- 19 March 2008
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 211 (2) , 574-584
- https://doi.org/10.1016/j.expneurol.2008.03.004
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (1R43NS44652-2)
This publication has 83 references indexed in Scilit:
- Development of Neurotrophic Factor Therapy for Alzheimer's DiseasePublished by Wiley ,2007
- Functional Outcomes of Drug Treatment in Alzheimer???s DiseaseDrugs & Aging, 2007
- Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged ratsCell Transplantation, 1996
- Nerve growth factor in Alzheimerʼs disease: defective retrograde transport to nucleus basalisNeuroReport, 1995
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the ratExperimental Neurology, 1991
- Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairmentsBrain Research, 1990
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978